US Patent 7556930 CD39L3 and its role in diabetes

Patent 7556930 was granted and assigned to Metabolex on July, 2009 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Patent Inventor Names

Maria E. Wilson0

Yuko Terasawa0

Jeffrey D. Johnson0

Date of Patent

July 7, 2009

Patent Application Number

114021420

Date Filed

April 10, 2006

Patent Primary Examiner

Patent abstract

The present invention provides for methods and compositions related to the involvement of CD39L3 in insulin production.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 7556930 CD39L3 and its role in diabetes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.